-
1
المؤلفون: Michela Verzè, Elisa Giovannetti, Alessandro Leonetti, Amir Avan, Roberta Minari, Alessandro Gregori, Mjriam Capula, Filippo Papini, Paola Bordi, Giulia Mazzaschi, Btissame El Hassouni, Marcello Tiseo
المساهمون: Medical oncology laboratory, CCA - Cancer biology and immunology, CCA - Imaging and biomarkers, Amsterdam Gastroenterology Endocrinology Metabolism
المصدر: Cells, 10(6):1520. MDPI Multidisciplinary Digital Publishing Institute
Leonetti, A, Capula, M, Minari, R, Mazzaschi, G, Gregori, A, el Hassouni, B, Papini, F, Bordi, P, Verzè, M, Avan, A, Tiseo, M & Giovannetti, E 2021, ' Dynamic Evaluation of Circulating miRNA Profile in EGFR-Mutated NSCLC Patients Treated with EGFR-TKIs ', Cells, vol. 10, no. 6, 1520 . https://doi.org/10.3390/cells10061520Test
Cells
Cells, Vol 10, Iss 1520, p 1520 (2021)
Volume 10
Issue 6مصطلحات موضوعية: Oncology, Circulating mirnas, Male, Lung Neoplasms, medicine.medical_treatment, Drug Resistance, Disease, Targeted therapy, Basal (phylogenetics), EGFR‐mutated NSCLC, Carcinoma, Non-Small-Cell Lung, Medicine, Biology (General), Non-Small-Cell Lung, Tumor, Gefitinib, General Medicine, Middle Aged, targeted therapy, Response to EGFR‐TKI, response to EGFR-TKI, ErbB Receptors, Female, EGFR-mutated NSCLC, Adult, medicine.medical_specialty, QH301-705.5, Antineoplastic Agents, Afatinib, Article, Erlotinib Hydrochloride, Statistical significance, Internal medicine, microRNA, Biomarkers, Tumor, Humans, Circulating MicroRNA, MiRNA, Aged, Drug Resistance, Neoplasm, MicroRNAs, Mutation, Protein Kinase Inhibitors, Retrospective Studies, miRNA, business.industry, Carcinoma, Retrospective cohort study, Fold change, respiratory tract diseases, Neoplasm, business, Biomarkers
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b195378c54aaed1b56ebdc037e6b7173Test
https://research.vumc.nl/en/publications/9f10a1ce-6a0e-421a-b323-08d160a0846fTest -
2
المؤلفون: Elisa Giovannetti, Vanesa Gregorc, Chiara Lazzari, Maria Giulia Cangi, Mariacarmela Santarpia, Alessandra Bulotta
المصدر: Lazzari, C, Gregorc, V, Cangi, M G, Giovannetti, E, Bulotta, A & Santarpia, M 2018, ' Combined exosomal RNA and circulating tumor DNA for epidermal growth factor mutation detection in non-small cell lung cancer ', Journal of Thoracic Disease, vol. 10, pp. S4023-S4027 . https://doi.org/10.21037/jtd.2018.10.17Test
Journal of thoracic disease (Online) 10 (2018): S4023–S4027. doi:10.21037/jtd.2018.10.17
info:cnr-pdr/source/autori:Lazzari C.; Gregorc V.; Cangi M.G.; Giovannetti E.; Bulotta A.; Santarpia M./titolo:Combined exosomal RNA and circulating tumor DNA for epidermal growth factor mutation detection in non-small cell lung cancer/doi:10.21037%2Fjtd.2018.10.17/rivista:Journal of thoracic disease (Online)/anno:2018/pagina_da:S4023/pagina_a:S4027/intervallo_pagine:S4023–S4027/volume:10مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Adult, Male, Lung Neoplasms, DNA Mutational Analysis, Antineoplastic Agents, Exosomes, Sensitivity and Specificity, Circulating Tumor DNA, Epidermal growth factor, Carcinoma, Non-Small-Cell Lung, medicine, ROS1, Biomarkers, Tumor, Anaplastic lymphoma kinase, Humans, Mutation detection, Lung cancer, Aged, Acrylamides, business.industry, Liquid Biopsy, RNA, Genes, erbB-1, Middle Aged, medicine.disease, ErbB Receptors, Editorial, Pyrimidines, Circulating tumor DNA, Cancer research, Female, Non small cell, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a85b54e65ba6cced812d1e88976ca0d2Test
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85057399178&origin=inwardTest -
3
المؤلفون: Henk L. Dekker, Elisa Giovannetti, Marcello Tiseo, Patrick Pauwels, Filip Lardon, Christian Rolfo, Kaylee Keller, Rob Ruijtenbeek, Alessandro Leonetti, Niccola Funel, Godefridus J. Peters, Nele Van Der Steen
المساهمون: Medical oncology laboratory, AGEM - Re-generation and cancer of the digestive system, CCA - Cancer biology and immunology
المصدر: Biochemical pharmacology
van der Steen, N, Leonetti, A, Keller, K, Dekker, H, Funel, N, Lardon, F, Ruijtenbeek, R, Tiseo, M, Rolfo, C, Pauwels, P, Peters, G J & Giovannetti, E 2019, ' Decrease in phospho-PRAS40 plays a role in the synergy between erlotinib and crizotinib in an EGFR and cMET wild-type squamous non-small cell lung cancer cell line ', Biochemical Pharmacology, vol. 166, pp. 128-138 . https://doi.org/10.1016/j.bcp.2019.05.014Test
Biochemical Pharmacology, 166, 128-138. Elsevier Inc.مصطلحات موضوعية: 0301 basic medicine, MAPK/ERK pathway, Male, Lung Neoplasms, Antineoplastic Agents, Biochemistry, 03 medical and health sciences, Erlotinib Hydrochloride, 0302 clinical medicine, Crizotinib, Carcinoma, Non-Small-Cell Lung, Cell Line, Tumor, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Epidermal growth factor receptor, Phosphorylation, Lung cancer, Protein kinase B, PI3K/AKT/mTOR pathway, Adaptor Proteins, Signal Transducing, Aged, Pharmacology, biology, Chemistry, Pharmacology. Therapy, Drug Synergism, Cell cycle, Middle Aged, Proto-Oncogene Proteins c-met, medicine.disease, ErbB Receptors, 030104 developmental biology, 030220 oncology & carcinogenesis, Cancer research, biology.protein, Female, Erlotinib, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::198c1da7976161631dcc7ca088486798Test
https://hdl.handle.net/10067/1611930151162165141Test -
4
المؤلفون: Jacobus A. Burgers, Godefridus J. Peters, Egbert F. Smit, Elisa Giovannetti, Francesco Di Costanzo, Andrea Ardizzoni, Carmelo Tibaldi, Andrea Camerini, Fausto Barbieri, Marcello Tiseo, Andrew D. Vincent
المساهمون: Medical oncology laboratory, Pulmonary medicine, CCA - Innovative therapy, Tiseo, Marcello, Giovannetti, Elisa, Tibaldi, Carmelo, Camerini, Andrea, Di Costanzo, Francesco, Barbieri, Fausto, Burgers, Jacobus A., Vincent, Andrew, Peters, Godefridus J., Smit, Egbert F., Ardizzoni, Andrea
المصدر: Lung Cancer, 78(1), 92-99. Elsevier Ireland Ltd
Tiseo, M, Giovannetti, E, Tibaldi, C, Camerini, A, Di Costanzo, F, Barbieri, F, Burgers, J A, Vincent, A D, Peters, G J, Smit, E F & Ardizzoni, A 2012, ' Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed-carboplatin ', Lung Cancer, vol. 78, no. 1, pp. 92-99 . https://doi.org/10.1016/j.lungcan.2012.07.009Testمصطلحات موضوعية: Male, Oncology, Cancer Research, Lung Neoplasms, non-small cell lung cancer (NSCLC), Pharmacology, Thymidylate synthase, Carboplatin, Antineoplastic Agent, Reduced Folate Carrier Protein, chemistry.chemical_compound, Gene Frequency, Glutamates, Retrospective Studie, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Allele, Aged, 80 and over, biology, Pharmacogenetic, Hazard ratio, Middle Aged, Treatment Outcome, Pemetrexed, Female, Glutamate, Human, medicine.drug, Adult, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Guanine, Genotype, Non-small cell lung cancer (NSCLC), Antineoplastic Agents, Polymorphism, Single Nucleotide, Internal medicine, medicine, Humans, Alleles, Methylenetetrahydrofolate Reductase (NADPH2), Aged, Neoplasm Staging, Retrospective Studies, Xeroderma Pigmentosum Group D Protein, Antineoplastic Combined Chemotherapy Protocol, business.industry, Proportional hazards model, Thymidylate Synthase, gamma-Glutamyl Hydrolase, MTHFR-C667T polymorphism, medicine.disease, Lung Neoplasm, chemistry, Methylenetetrahydrofolate reductase, biology.protein, business, Pharmacogenetics
وصف الملف: ELETTRONICO
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e75b870f6ebcd4b15db069e24f07cf1Test
https://doi.org/10.1016/j.lungcan.2012.07.009Test -
5
المساهمون: Medical oncology laboratory, CCA - Innovative therapy
المصدر: Journal of Cancer Research and Clinical Oncology, 141(7), 1189-1194. Springer Verlag
Vasile, E, Tibaldi, C, Leon, G L, D'Incecco, A & Giovannetti, E 2015, ' Cytochrome P450 1B1 (CYP1B1) polymorphisms are associated with clinical outcome of docetaxel in non-small cell lung cancer (NSCLC) patients ', Journal of Cancer Research and Clinical Oncology, vol. 141, no. 7, pp. 1189-1194 . https://doi.org/10.1007/s00432-014-1880-3Testمصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, CYP1B1, medicine.medical_treatment, non-small cell lung cancer (NSCLC), Antineoplastic Agents, Single-nucleotide polymorphism, Docetaxel, Polymorphism, Single Nucleotide, Biomarkers, Pharmacological, Polymorphism (computer science), Carcinoma, Non-Small-Cell Lung, Internal medicine, Tumor Cells, Cultured, medicine, Carcinoma, Humans, neoplasms, Genetic Association Studies, Aged, Retrospective Studies, Aged, 80 and over, Chemotherapy, Hematology, business.industry, General Medicine, Middle Aged, Prognosis, medicine.disease, body regions, Treatment Outcome, Chemotherapy, Adjuvant, Cytochrome P-450 CYP1B1, Female, Taxoids, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c5595da0c67b8409b2e8a1b7b1b23d1Test
https://research.vumc.nl/en/publications/96018efa-575a-443a-b58a-d1486c35ebb8Test -
6
المؤلفون: O. W. M. Meijer, Geertjan van Tienhoven, Henk M.W. Verheul, Elisa Giovannetti, Anna M.E. Bruynzeel, Annette A. van Zweeden, Maarten A J M Jacobs, Johanna W. Wilmink, Geert Kazemier, Hans J. van der Vliet, Martijn R. Meijerink
المساهمون: Cancer Center Amsterdam, Oncology, Radiotherapy, Medical oncology, Radiology and nuclear medicine, Radiation Oncology, Medical oncology laboratory, Surgery, Gastroenterology and hepatology, CCA - Innovative therapy
المصدر: van Zweeden, A A, van der Vliet, H J, Wilmink, J W, Meijerink, M R, Meijer, O W M, Bruynzeel, A M E, van Tienhoven, G, Giovannetti, E, Kazemier, G, Jacobs, M A J M & Verheul, H M W 2015, ' Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic Cancer ', Clinical Cancer Research, vol. 21, no. 20, pp. 4569-4575 . https://doi.org/10.1158/1078-0432.CCR-14-3364Test
Clinical cancer research, 21(20), 4569-4575. American Association for Cancer Research Inc.
Clinical Cancer Research, 21(20), 4569-4575. American Association for Cancer Research Inc.مصطلحات موضوعية: Male, Oncology, Radiation-Sensitizing Agents, Cancer Research, medicine.medical_specialty, Maximum Tolerated Dose, Combination therapy, medicine.medical_treatment, Phases of clinical research, Antineoplastic Agents, Deoxycytidine, Disease-Free Survival, Internal medicine, medicine, Humans, Panitumumab, Progression-free survival, Aged, Performance status, business.industry, Antibodies, Monoclonal, Chemoradiotherapy, Middle Aged, Combined Modality Therapy, Gemcitabine, ErbB Receptors, Pancreatic Neoplasms, Radiation therapy, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8af044d3aa10a3aa41b4670af9233d5aTest
https://research.vumc.nl/en/publications/d841b4b3-1d46-4e67-931c-ea9631b374d0Test -
7
المؤلفون: Clara Lemos, Gl Scheffer, G. Giaccone, Elisa Giovannetti, Carmelo Tibaldi, G.J. Peters, T. van der Straaten, H-J Guchelaar, Pa Zucali, Alfredo Falcone, Armando Santoro, Yg Assaraf, Romano Danesi, Armida D'Incecco
المساهمون: Medical oncology, Medical oncology laboratory, Pathology, CCA - Innovative therapy
المصدر: Pharmacogenomics, 12(2), 159-170
Lemos, C, Giovannetti, E, Zucali, P A, Assaraf, Y G, Scheffer, G L, van der Straaten, T, D'Incecco, A, Falcone, A, Guchelaar, H J, Danesi, R, Santoro, A, Giaccone, G, Tibaldi, C & Peters, G J 2011, ' Impact of ABCG2 polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients ', Pharmacogenomics, vol. 12, no. 2, pp. 159-170 . https://doi.org/10.2217/pgs.10.172Test
Pharmacogenomics
Pharmacogenomics, 12(2), 159-170. Future Medicine Ltd.مصطلحات موضوعية: Male, Oncology, Lung Neoplasms, Abcg2, gefitinib, Genome-wide association study, NSCLC, Carcinoma, Non-Small-Cell Lung, Genotype, ATP Binding Cassette Transporter, Subfamily G, Member 2, Precision Medicine, pharmacogenetics, biology, Middle Aged, Neoplasm Proteins, Treatment Outcome, embryonic structures, Toxicity, Molecular Medicine, Female, medicine.drug, Diarrhea, medicine.medical_specialty, ABCG2, animal structures, Antineoplastic Agents, Article, Gefitinib, Internal medicine, Genetics, medicine, Humans, Lung cancer, Pharmacology, Polymorphism, Genetic, business.industry, Haplotype, toxicity, medicine.disease, respiratory tract diseases, lung cancer, Haplotypes, Quinazolines, Cancer research, biology.protein, ATP-Binding Cassette Transporters, sense organs, business, Pharmacogenetics, Genome-Wide Association Study
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89d8dbdb68ab3323182687faf44033e8Test
https://doi.org/10.2217/pgs.10.172Test -
8
المؤلفون: Ilaria Pastina, Sergio Ricci, Tristan M. Sissung, Romano Danesi, Douglas K. Price, William D. Figg, Cinzia Orlandini, Aldo Chioni, C. Cianci, Francesco Crea, Elisa Giovannetti
المساهمون: Medical oncology laboratory, CCA - Innovative therapy
المصدر: BMC Cancer, 10. BioMed Central
BMC Cancer
Pastina, I, Giovannetti, E, Chioni, A, Sissung, T M, Crea, F, Orlandini, C, Price, D K, Cianci, C, Figg, W D, Ricci, S & Danesi, R 2010, ' Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients ', BMC Cancer, vol. 10, pp. 511 . https://doi.org/10.1186/1471-2407-10-511Test
BMC Cancer, Vol 10, Iss 1, p 511 (2010)مصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, Cancer Research, Genotype, medicine.medical_treatment, CYP1B1, Antineoplastic Agents, Pharmacology, lcsh:RC254-282, Prostate cancer, Surgical oncology, Internal medicine, medicine, Genetics, Humans, pharmacogenetics, docetaxel, prostate cancer, Aged, Aged, 80 and over, Chemotherapy, Predictive marker, Polymorphism, Genetic, business.industry, Prostatic Neoplasms, Middle Aged, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Regimen, Treatment Outcome, Docetaxel, Drug Resistance, Neoplasm, Cytochrome P-450 CYP1B1, Multivariate Analysis, Taxoids, Aryl Hydrocarbon Hydroxylases, business, Pharmacogenetics, medicine.drug, Research Article
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8d4b7502b090bab3a294e49896ddfdcTest
https://research.vumc.nl/en/publications/e3d52b71-e2c3-4422-b169-fb26d797e27bTest -
9
المؤلفون: Generoso Bevilacqua, Luca Pollina, Elisa Giovannetti, Sara Nannizzi, Franco Mosca, Valentina Mey, Mario Del Tacca, Romano Danesi, Niccola Funel, S. Ricciardi, Daniela Campani, Marco Del Chiaro, Ugo Boggi
المساهمون: Medical oncology laboratory, CCA - Disease profiling
المصدر: Laboratory Investigation, 88(7), 773-784. Nature Publishing Group
Funel, N, Giovannetti, E, Del Chiaro, M, Mey, V, Pollina, L E, Nannizzi, S, Boggi, U, Ricciardi, S, Del Tacca, M, Bevilacqua, G, Mosca, F, Danesi, R & Campani, D 2008, ' Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma ', Laboratory Investigation, vol. 88, no. 7, pp. 773-784 . https://doi.org/10.1038/labinvest.2008.40Testمصطلحات موضوعية: Male, Pathology, Messenger, Tetrazolium Salts, Deoxycytidine, Gene expression, 80 and over, Tumor Markers, Microdissection, Cells, Cultured, Laser capture microdissection, Oligonucleotide Array Sequence Analysis, Aged, 80 and over, Adult, Aged, Aged, 80 and over, Antineoplastic Agents, pharmacology, Carcinoma, Pancreatic Ductal, metabolism/pathology, Cells, Cultured, Deoxycytidine, analogs /&/ derivatives/pharmacology, Female, Fluorouracil, pharmacology, Humans, Lasers, Male, Microdissection, methods, Middle Aged, Oligonucleotide Array Sequence Analysis, Pancreatic Neoplasms, metabolism/pathology, RNA, biosynthesis/isolation /&/ purification, Tetrazolium Salts, pharmacology, Thiazoles, pharmacology, Tumor Markers, Biological, metabolism, Cultured, Middle Aged, Primary tumor, Real-time polymerase chain reaction, Adenocarcinoma, Female, Fluorouracil, biosynthesis/isolation /&/ purification, Carcinoma, Pancreatic Ductal, metabolism/pathology, Adult, medicine.medical_specialty, Stromal cell, Cells, Immunocytochemistry, Antineoplastic Agents, Biology, methods, Pathology and Forensic Medicine, medicine, Biomarkers, Tumor, Humans, RNA, Messenger, Molecular Biology, Aged, Lasers, Carcinoma, Cell Biology, medicine.disease, Gemcitabine, Pancreatic Neoplasms, Thiazoles, Cancer research, RNA, pharmacology, analogs /&/ derivatives/pharmacology
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1344b44d30fd842a64f19505ec80a80Test
https://pubmed.ncbi.nlm.nih.gov/18490900Test -
10
المؤلفون: Armando Santoro, Alfredo Falcone, Giuseppe Giaccone, Godefridus J. Peters, Jacobus A. Burgers, Elisa Giovannetti, Romano Danesi, Armida D'Incecco, Paolo Andrea Zucali, Carmelo Tibaldi, Filippo Cortesi, Egbert F. Smit
المساهمون: Medical oncology laboratory, Pulmonary medicine, CCA - Innovative therapy
المصدر: Web of Science
Molecular Cancer Therapeutics, 9(3), 581-593. American Association for Cancer Research Inc.
Giovannetti, E, Zucali, P A, Peters, G J, Cortesi, F, D'Incecco, A, Smit, E F, Falcone, A, Burgers, J A, Santoro, A, Danesi, R, Giaccone, G & Tibaldi, C 2010, ' Association of Polymorphisms in AKT1 and EGFR with Clinical Outcome and Toxicity in Non-Small Cell Lung Cancer Patients Treated with Gefitinib ', Molecular Cancer Therapeutics, vol. 9, no. 3, pp. 581-593 . https://doi.org/10.1158/1535-7163.MCT-09-0665Test
Università di Pisa-IRIS
Publonsمصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Drug-Related Side Effects and Adverse Reactions, Population, Antineoplastic Agents, Pharmacology, Polymorphism, Single Nucleotide, Biomarkers, Pharmacological, Gefitinib, Internal medicine, Carcinoma, Non-Small-Cell Lung, Genotype, medicine, Humans, Epidermal growth factor receptor, Lung cancer, education, neoplasms, Survival analysis, Aged, Retrospective Studies, Aged, 80 and over, education.field_of_study, biology, business.industry, Middle Aged, medicine.disease, Prognosis, Survival Analysis, respiratory tract diseases, ErbB Receptors, Treatment Outcome, Drug Resistance, Neoplasm, biology.protein, Quinazolines, Biomarker (medicine), Female, business, Proto-Oncogene Proteins c-akt, Pharmacogenetics, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9fc4b7b10a929beaed8b02a975360daTest
https://publons.com/wos-op/publon/27272248Test/
